Abstract: A concrete inside interface processing structure for secant pile construction, including secant concrete pile, formed plain concrete pile, rotary jet grouting piles, steel mesh sheet, ribbed steel bar, Y-shaped connecting piece, reinforced concrete pile, and U-shaped connecting piece; drilled holes are arranged at intervals along axis of the formed plain concrete pile; the ribbed steel bar is anchored in each drilled hole; the steel mesh sheet is formed by connecting longitudinal bars and transverse bars, and driven into a soil body between the formed plain concrete piles; the concrete layer is formed by spraying concrete on the steel mesh sheet; the reinforced concrete pile is cast at outside of the formed plain concrete pile, and tangent to the formed plain concrete pile, and interlocked with the rotary jet grouting piles; the rotary jet grouting piles are tangent to the formed plain concrete pile or secant concrete pile.

Abstract: A concrete inside interface processing structure for secant pile construction, including secant concrete pile, formed plain concrete pile, rotary jet grouting piles, steel mesh sheet, ribbed steel bar, Y-shaped connecting piece, reinforced concrete pile, and U-shaped connecting piece; drilled holes are arranged at intervals along axis of the formed plain concrete pile; the ribbed steel bar is anchored in each drilled hole; the steel mesh sheet is formed by connecting longitudinal bars and transverse bars, and driven into a soil body between the formed plain concrete piles; the concrete layer is formed by spraying concrete on the steel mesh sheet; the reinforced concrete pile is cast at outside of the formed plain concrete pile, and tangent to the formed plain concrete pile, and interlocked with the rotary jet grouting piles; the rotary jet grouting piles are tangent to the formed plain concrete pile or secant concrete pile.

Abstract: The invention relates to pharmaceutical formulations and methods for preparing pharmaceutical formulations of histamine releasers. The present invention provides methods for determining the concentration of physiologically acceptable excipients for use in the formulations of the invention. The present invention also provides methods for suppressing pharmaceutically-induced histamine release by administering to an animal, the formulations of the present invention. A kit useful for preparing pharmaceutical formulations of histamine releasers is also provided.